StockGlow

Galera Therapeutics, Inc. (GRTXD)

Develops drugs that protect healthy cells during cancer radiation therapy.

$15.57+0.02%Healthcare
Compare GRTXD with
StockGlow Score
58
Neutral
BearishBullish
1 year ago+238.5%

The outlook

GRTXD is trading near the lower end of its 52-week range and shows mixed momentum against its moving averages. Analyst coverage appears sparse. The stock sits with a neutral lean based on current market positioning.

What’s behind the score

Price trendMixed vs its moving averages
52-week range47% of the way from its 52-week low to high
Market cap
$16.2M
52-wk high
$30.00
52-wk low
$3.00
50-day avg
$18.26
200-day avg
$10.32
Trailing P/E
0.1

Similar stocks

PTPIPetros Pharmaceuticals, Inc.$0.00+0.00%BFRIBiofrontera Inc.$1.11+5.71%ENSCEnsysce Biosciences, Inc.$0.25-4.05%ARDSAridis Pharmaceuticals, Inc.$0.00+0.00%KTTAPasithea Therapeutics Corp.$0.45+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy